Use of Warfarin After the First Trimester in Pregnant Women With APS

Status Recruiting

Clinical Trial Summary

Evaluation of shifting to oral vitamin K antagonist after the first trimester instead of using low molecular weight heparin (LMWH) throughout pregnancy in pregnant women with antiphospholipid syndrome (APS)

Clinical Trial Description

Women will be randomly divided into two groups; one will be subjected to anticoagulant therapy by Enoxaparin throughout pregnancy and the other will be subjected to anticoagulant therapy by Enoxaparin in the first trimester then Warfarin after the first trimester until termination of pregnancy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02303171
Study type	Interventional
Source	Mansoura University
Contact	Mohamed I Eid, Dr
Phone	+201225401274
Email	dr_moh_eid@yahoo.com
Status	Recruiting
Phase	Phase 4
Start date	November 2014
Completion date	June 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01475149` - Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE)	N/A
Completed	`NCT00537290` - A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome	Phase 2
Recruiting	`NCT00616317` - Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
Recruiting	`NCT00198068` - Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
Completed	`NCT00180817` - Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
Completed	`NCT03682419` - Evaluation of Precision and Accuracy of INR Measurements in a Point of Care Device (OPTIMAL)	N/A
Not yet recruiting	`NCT03303508` - Measurement of Anti-dsDNA by Both CLIFT & ELISA	N/A
Recruiting	`NCT04262492` - International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants
Withdrawn	`NCT00180778` - Steroids and Antiphospholipid Syndrome- Related Pregnancy Loss	Phase 1/Phase 2
Enrolling by invitation	`NCT05583305` - Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome
Recruiting	`NCT05644210` - Telitacicept Followed With Rituximab Therapy on APS Secondary to SLE
Completed	`NCT00674297` - Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients	Phase 2
Recruiting	`NCT05859997` - Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases	N/A
Recruiting	`NCT06373003` - Negative Antiphospholipid Syndrome: a Multicentric Study
Recruiting	`NCT06373926` - Evaluation of Cell Membrane Expression of Annexin A2 on Monocytes by Flow Cytometry in Primary Antiphospholipid Syndrome	N/A
Recruiting	`NCT01818505` - The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome	N/A
Completed	`NCT00878137` - Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin	N/A
Completed	`NCT01104337` - Drug Interaction Between Paracetamol and Warfarin	Phase 4
Completed	`NCT05313048` - Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vaccination
Recruiting	`NCT03890601` - New Biological Tests in Patients With Antiphospholipid Antibodies